细菌菌体:现状和新兴趋势朝着一个健康方法的方向发展
Rachel Samson1, Mahesh Dharne1, Krishna Khairnar2
1National Collection of Industrial Microorganisms (NCIM), Biochemical Sciences Division, CSIR-National Chemical Laboratory (NCL), Pune 411008, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India.
The Science of the total environment
|November 15, 2023
概括
抗菌素耐药性 (AMR) 需要新的解决方案. 菌体 (菌体) 具有强大,特定的抗微生物活性和多种应用,在"一个健康"框架内解决关键的健康和安全挑战.
科学领域:
- 微生物学和生物技术
- 一个健康框架应用程序
背景情况:
- 由ESKAPEE病原体引起的抗微生物耐药性 (AMR) 的升级需要替代治疗方法.
- 现有的疗法对抗耐药微生物越来越无效.
- 菌体 (菌体) 是对抗AMR的有希望的生物资源.
研究的目的:
- 审查菌体的多方面的应用.
- 探索生物医学,农业,环境和工业部门的菌体潜力.
- 为了突出菌体融合在一个健康的概念.
主要方法:
- 对最近最先进的研究进行了全面的文献综述.
- 巩固整合人类,动物,植物和环境健康的研究.
- 菌体属性的分析,应用和商业化.
主要成果:
- 菌体具有显著的生物医学和药理学优势,具有有希望的体内和临床数据.
- 菌体技术可以适应先进的应用,包括药物输送,生物传感,成像和催化.
- 菌体在对影响植物,食品和动物的病原体进行生物控制方面表现出有效性.
结论:
- 菌体是多功能生物剂,在治疗AMR及其他方面具有广泛的适用性.
- 基于菌体的产品的进一步开发和商业化至关重要.
- 菌体应用与整合健康解决方案的One Health战略保持一致.
相关概念视频
Lytic Cycle of Bacteriophages
70.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
DNA Bacteriophages
27
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
27
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Viral Replication: Lysogenic Cycle
30
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
30
Lysogenic Cycle of Bacteriophages
62.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.2K
Transduction
20
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
20


